We are live on !
Find out more
Vitruvian Partners Portfolio holdings
AUM
$201M
Turnover
12.5%
1-Year Est. Return
10.44%
This Fund
S&P 500
This Quarter Est. Return
+37.96%
1 Year Est. Return
+10.44%
3 Year Est. Return
+64.35%
5 Year Est. Return
-5.3%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$89.1M
(+80%)
Cap. Flow
-$41.8M
Cap. Flow % of AUM
Cap. Flow %
-20.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
3
Closed
–
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wise Group
WSE
|
+$3.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hinge Health
HNGE
|
+$40.4M |
| 2 |
CarGurus
CARG
|
+$3.98M |
| 3 |
Xometry
XMTR
|
+$768K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 57.05% |
| 2 | Healthcare | 24.68% |
| 3 | Industrials | 8.7% |
| 4 | Communication Services | 5.94% |
| 5 | Consumer Discretionary | 3.63% |
Similar funds
Vitruvian Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Vitruvian Partners held 8 positions worth $201M, up 80% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vitruvian Partners withdrew a net $41.8M in Q2 2026, reducing 3 holdings. Its largest reduction was Hinge Health, cutting an estimated $40.4M.
By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Vitruvian Partners opened a new position in Wise Group worth $3.35M.
- Vitruvian Partners's largest Q2 2026 buy was Wise Group: 281,277 shares worth $3.35M.
- Vitruvian Partners's biggest Q2 2026 reduction was Hinge Health, cutting an estimated $40.4M.
- Vitruvian Partners's ten largest holdings make up 100% of its $201M portfolio in Q2 2026.
- Vitruvian Partners opened 1 new position and closed 0 in Q2 2026.
- Vitruvian Partners's portfolio value rose 80% quarter-over-quarter to $201M.
Based on Vitruvian Partners's 13F filing for Q2 2026, filed 10 Aug 2026.